CMMB

Chemomab Therapeutics Ltd. - American Depositary Shares (CMMB)

About Chemomab Therapeutics Ltd. - American Depositary Shares (CMMB)

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

Details

Daily high

$2.17

Daily low

$2.02

Price at open

$2.12

52 Week High

$9.84

52 Week Low

$2.01

Market cap

12.7M

Dividend yield

0.00%

Volume

85,426

Avg. volume

98,265

P/E ratio

-1.11

Chemomab Therapeutics Ltd. - American Depositary Shares News